Towa Profits Take 87% Nosedive In Face Of Increased Costs
Firm Has Further Lowered Its Annual Estimates Following November Revision
Japanese generics firm Towa has seen its profits slashed as increased expenses stemming from its acquisition of Sunsho Pharmaceutical decimated its bottom line in Q3.
